Amoxicillin/Clavulanate 875/125mg Dosing
The correct dose for amoxicillin/clavulanate 875/125mg is one tablet twice daily (every 12 hours), which delivers a total daily dose of 1750mg amoxicillin and 250mg clavulanate. 1
Standard Adult Dosing
- One 875/125mg tablet every 12 hours is the FDA-approved regimen for more severe infections and respiratory tract infections 1
- This formulation is specifically designed for twice-daily dosing and should not be substituted with other strengths 1
- The 875/125mg dose is recommended by the Infectious Diseases Society of America specifically for respiratory infections including acute bacterial rhinosinusitis, community-acquired pneumonia, and acute exacerbations of chronic bronchitis 2
Clinical Context and Rationale
- The 875/125mg twice-daily regimen provides adequate time above the minimum inhibitory concentration (T>MIC) for most common respiratory pathogens 3
- This dose achieves approximately 4g/day of amoxicillin, which meets the "high-dose" threshold defined in treatment guidelines for overcoming penicillin-resistant Streptococcus pneumoniae 3
- The formulation maintains coverage against beta-lactamase-producing organisms (H. influenzae, M. catarrhalis) through the clavulanate component 3
Treatment Duration
- For uncomplicated acute bacterial rhinosinusitis: 5-7 days 2
- For chronic rhinosinusitis or acute exacerbations: 14 days 3
- Duration should be based on the specific infection type and clinical response 2
Administration Guidelines
- Take at the start of meals to enhance clavulanate absorption and minimize gastrointestinal side effects 1
- May be taken without regard to meals, but meal-time administration is preferred for tolerability 1
Critical Dosing Warnings
- Never substitute two 250/125mg tablets for one 500/125mg tablet - this results in excessive clavulanate dosing (250mg vs 125mg) 2, 1
- Do not substitute two 500/125mg tablets for one 875/125mg tablet - the clavulanate content differs and this is not an equivalent substitution 1
- Patients weighing ≥40kg should follow adult dosing recommendations 1
Renal Dosing Adjustments
- No dose adjustment needed unless glomerular filtration rate (GFR) <30 mL/min 1
- GFR <30 mL/min: Do not use the 875/125mg formulation - switch to 500/125mg or 250/125mg formulations 1
- GFR 10-30 mL/min: Use 500/125mg or 250/125mg every 12 hours 1
- GFR <10 mL/min or hemodialysis: Use 500/125mg or 250/125mg every 24 hours, with additional dose during and after dialysis 1
Evidence for Efficacy
- The 875/125mg twice-daily regimen demonstrated clinical success rates of 91-93% in acute exacerbations of chronic bronchitis 4
- This formulation showed 92.3% efficacy against S. pneumoniae in community-acquired pneumonia, including penicillin-resistant strains 5
- Studies comparing 875/125mg twice daily versus 500/125mg three times daily showed comparable clinical outcomes in chronic rhinosinusitis 3